UK based Pharma company pauses COVID vaccine over ‘Unexplained illness’

Pharmaceutical company AstraZeneca said Tuesday it had “voluntarily paused” a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.

“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow the review of safety data by an independent committee,” a spokesperson said.

Also Read: Russia to release COVID vaccine for civilians from next week

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”

“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the spokesperson added.

Readers like you make Inside Northeast’s work possible.

To support our brand of fearless and investigative journalism, support us HERE.

Download:

The Inside Northeast app HERE for News, Views, and Reviews from Northeast India.

Do keep following us for news on-the-go. We deliver the Northeast.